STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATYR
  4. [ARS] aTYR PHARMA INC SEC Filing

[ARS] aTYR PHARMA INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - aTYR PHARMA INC

ARS Filing - aTYR PHARMA INC

This filing is available as a PDF document.

Filing Type: ARS

Company: aTYR PHARMA INC (ATYR)

Acceptance Date: 2026-03-26T16:10:33.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Atyr Pharma Inc

NASDAQ:ATYR

View ATYR Stock Overview →

ATYR Rankings

#5273 Ranked by Market Cap
N/A Ranked by Dividends

ATYR Latest News

Mar 5, 2026
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
Feb 20, 2026
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 18, 2026
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
Feb 3, 2026
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
Nov 10, 2025
aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

ATYR Latest SEC Filings

Mar 26, 2026
[SCHEDULE 13G/A] aTYR PHARMA INC Amended Passive Investment Disclosure
Mar 26, 2026
[DEF 14A] aTYR PHARMA INC Definitive Proxy Statement
Mar 12, 2026
[PRE 14A] aTYR PHARMA INC Preliminary Proxy Statement
Mar 5, 2026
[10-K] aTYR PHARMA INC Files Annual Report
Mar 5, 2026
[8-K] aTYR PHARMA INC Reports Material Event

ATYR Stock Data

77.73M
96.64M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SAN DIEGO